Cargando…

Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma

SIMPLE SUMMARY: Clear cell renal cell carcinoma (ccRCC) is the predominant cause of kidney cancer death attributed to its prevalence (70%) and its nature being the most aggressive form of kidney cancer. Most ccRCC deaths are resulted from metastasis. It is essential to know which ccRCCs are at risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xiaozeng, Kapoor, Anil, Gu, Yan, Chow, Mathilda Jing, Peng, Jingyi, Major, Pierre, Tang, Damu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700485/ https://www.ncbi.nlm.nih.gov/pubmed/33266355 http://dx.doi.org/10.3390/cancers12113471

Ejemplares similares

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
por: Lin, Xiaozeng, et al.
Publicado: (2022)

Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel towards Prostate Cancer Relapse
por: Gu, Yan, et al.
Publicado: (2021)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

Contributions of DNA Damage to Alzheimer’s Disease
por: Lin, Xiaozeng, et al.
Publicado: (2020)

Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma
por: Chow, Mathilda Jing, et al.
Publicado: (2021)

The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert
por: Gu, Yan, et al.
Publicado: (2020)

The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
por: Rodriguez, David, et al.
Publicado: (2019)

Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network
por: Gu, Yan, et al.
Publicado: (2021)

Insights of RKIP-Derived Suppression of Prostate Cancer
por: Dong, Ying, et al.
Publicado: (2021)

The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis
por: Mei, Wenjuan, et al.
Publicado: (2019)

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors
por: Lin, Xiaozeng, et al.
Publicado: (2023)

PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity
por: Gu, Yan, et al.
Publicado: (2023)

Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3
por: Lin, Xiaozeng, et al.
Publicado: (2023)

Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence
por: Jiang, Yanzhi, et al.
Publicado: (2018)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma
por: Hill, Brianne, et al.
Publicado: (2014)

Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis
por: Gu, Yan, et al.
Publicado: (2020)

Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle
por: Xie, Yanyun, et al.
Publicado: (2016)

Amplification of MUC1 in prostate cancer metastasis and CRPC development
por: Wong, Nicholas, et al.
Publicado: (2016)

Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer
por: Ojo, Diane, et al.
Publicado: (2015)

BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015)

Clinical experience with multigene carrier panels in the reproductive setting
por: Terhaar, Catherine, et al.
Publicado: (2018)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development
por: Gu, Yan, et al.
Publicado: (2018)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

The Benefit of Multigene Panel Testing for the Diagnosis and Management of the Genetic Epilepsies
por: Leduc-Pessah, Heather, et al.
Publicado: (2022)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression
por: Lin, Xiaozeng, et al.
Publicado: (2017)

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Jifeng, et al.
Publicado: (2023)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

FAM84B promotes prostate tumorigenesis through a network alteration
por: Jiang, Yanzhi, et al.
Publicado: (2019)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma
por: LIU, LUNZHI, et al.
Publicado: (2014)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3f1esp0ouo3u2s456798uun1t5